A previously published study showed higher ALYREF protein expression in tumor tissue compared to normal breast tissue [20] and using a publicly available cohort of breast cancer patients (n = 65), high ALYREF protein expression was associated with worse patient survival (Fig. S1G). Here, ALYREF is linked to breast carcinoma.